Latest Close
$6.32
Stock Hub
AEMD
Aethlon Medical, Inc.
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. Use the sections below to move between chart, technical analysis, fundamentals, and news.
1y Change
-$32.68 (-83.79%)
Market Cap
$4,494,379.00
Sector
Healthcare
Industry
Medical Devices
Recommendation
hold
52W Range
$1.41 to $41.50
Target Mean Price
$13.25
Beta
1.40
Trailing P/E
Not available
Forward P/E
-11.09
Price / Book
0.58
Company Overview
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.